KESTRA MEDICAL TECHNOLOGIES, LTD.
For the period ended Jul 31, 2026. Filed Sep 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2026 · Filed Sep 14, 2026
KMTS$29.55-1.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Deficit)
| Common Shares · AdditionalPaid-In · Accumulated Other · Accumulated · TotalShareholders’ | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount · Capital · Comprehensive Loss · Deficit · Equity (Deficit) | |||||||
| Balances at April 30, 2025 | 51,348,656 | $51,349 | $674,306 | $ | - | $(520,249) | $205,406 |
| Share-based compensation expense | — | — | 4,579 | — | — | 4,579 | |
| Net loss and comprehensive loss | — | — | — | — | (25,826) | (25,826) | |
| Balances at July 31, 2025 | 51,348,656 | $51,349 | $678,885 | $ | - | $(546,075) | $184,159 |
| Common Shares · AdditionalPaid-In · Accumulated Other · Accumulated · TotalShareholders’ | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Capital | Comprehensive Loss | Deficit | Equity (Deficit) | |
| Balances at April 30, 2026 | 58,383,924 | $58,384 | $853,353 | $(218) | $(651,861) | $259,658 |
| Share-based compensation expense | — | — | 9,517 | — | — | 9,517 |
| Issuance of common shares - stock option exercises | 67,059 | 67 | 1,073 | — | — | 1,140 |
| Issuance of common shares - employee stock purchase plan | 60,245 | 60 | 1,238 | — | — | 1,298 |
| Issuance of common shares - restricted stock unit vesting | 760,657 | 761 | (761) | — | — | — |
| Tax withholdings on restricted stock unit vesting | — | — | (4,916) | — | — | (4,916) |
| Other comprehensive loss | — | — | — | (253) | — | (253) |
| Net loss | — | — | — | — | (44,087) | (44,087) |
| Balance at July 31, 2026 | 59,271,885 | $59,272 | $859,504 | $(471) | $(695,948) | $222,357 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.